Journey Medical Statistics Share Statistics Journey Medical has 23.3M
shares outstanding. The number of shares has increased by 12.39%
in one year.
Shares Outstanding 23.3M Shares Change (YoY) 12.39% Shares Change (QoQ) 11.52% Owned by Institutions (%) 22.19% Shares Floating 11.92M Failed to Deliver (FTD) Shares 1,496 FTD / Avg. Volume 1.1%
Short Selling Information The latest short interest is 1.11M, so 4.78% of the outstanding
shares have been sold short.
Short Interest 1.11M Short % of Shares Out 4.78% Short % of Float 9.37% Short Ratio (days to cover) 7.81
Valuation Ratios The PE ratio is -5.44 and the forward
PE ratio is 8.37.
Journey Medical's PEG ratio is
-0.02.
PE Ratio -5.44 Forward PE 8.37 PS Ratio 1.42 Forward PS 1.7 PB Ratio 3.98 P/FCF Ratio -8.75 PEG Ratio -0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Journey Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.37,
with a Debt / Equity ratio of 1.25.
Current Ratio 1.37 Quick Ratio 0.96 Debt / Equity 1.25 Debt / EBITDA -2.99 Debt / FCF -2.75 Interest Coverage -5.07
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.37M Profits Per Employee $-357.85K Employee Count 41 Asset Turnover 0.7 Inventory Turnover 1.45
Taxes Income Tax 61K Effective Tax Rate -0.42%
Stock Price Statistics The stock price has increased by 86.49% in the
last 52 weeks. The beta is 0.81, so Journey Medical's
price volatility has been higher than the market average.
Beta 0.81 52-Week Price Change 86.49% 50-Day Moving Average 7.19 200-Day Moving Average 5.96 Relative Strength Index (RSI) 57.73 Average Volume (20 Days) 136,287
Income Statement In the last 12 months, Journey Medical had revenue of 56.13M
and earned -14.67M
in profits. Earnings per share was -0.72.
Revenue 56.13M Gross Profit 35.26M Operating Income -13.68M Net Income -14.67M EBITDA -8.4M EBIT -11.91M Earnings Per Share (EPS) -0.72
Full Income Statement Balance Sheet The company has 20.3M in cash and 25.08M in
debt, giving a net cash position of -4.78M.
Cash & Cash Equivalents 20.3M Total Debt 25.08M Net Cash -4.78M Retained Earnings -87.03M Total Assets 84.96M Working Capital 13.76M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.13M
and capital expenditures 0, giving a free cash flow of -9.13M.
Operating Cash Flow -9.13M Capital Expenditures n/a Free Cash Flow -9.13M FCF Per Share -0.45
Full Cash Flow Statement Margins Gross margin is 62.81%, with operating and profit margins of -24.36% and -26.14%.
Gross Margin 62.81% Operating Margin -24.36% Pretax Margin -26.03% Profit Margin -26.14% EBITDA Margin -14.96% EBIT Margin -24.36% FCF Margin -16.26%
